Collection of Blood From Patients With Pancytopenia
Lymphocytapheresis of Patients With Pancytopenia
2 other identifiers
observational
38
1 country
1
Brief Summary
Aplastic anemia is a condition in which the cells normally found in blood are greatly decreased. The normal levels of white blood cells, red blood cells, and platelets are much lower in patients with aplastic anemia. Because of these low levels of blood cells, patients with aplastic anemia have a variety of immune system abnormalities. However, low levels of blood cells make it difficult to collect specialized white blood cells (mononuclear cells) for research studies. This study was designed to collect lymphocytes from patients with low levels of all blood cells (pancytopenia) for use in research. Patients participating in the study will undergo a special procedure known as lymphapheresis. During lymphapheresis blood is taken from the patient in a manner similar to blood donation. The white blood cells are selectively removed by spinning (centrifugation), and the remaining red blood cells and platelets are placed back (re-infused) into the donor s blood stream. Patients participating in this study will not benefit directly from it. However, cells collected in this study may increase scientific knowledge and improve understanding and treatment for diseases like aplastic anemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 1986
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 1986
CompletedFirst Submitted
Initial submission to the registry
November 3, 1999
CompletedFirst Posted
Study publicly available on registry
November 4, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 19, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 17, 2020
CompletedAugust 21, 2020
August 1, 2020
22.7 years
November 3, 1999
August 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Goal was to obtain adequate numbers of cells for laboratory studies from pancytopenic patients in whom simple phlebotomy is inadequate.
To obtain enough cells if phlebotomy inadequate.
1 day
Study Arms (1)
Group 1
Patients with pancytopenia
Eligibility Criteria
Patients with pancytopenia@@@
You may qualify if:
- All patients with aplastic anemia or other bone marrow failure in which we would not expect to obtain 1 X 10(8) mononuclear cells from 100 mls of peripheral blood (i.e. an absolute lymphocyte count approximately less than 2000 per mm(3)).
- Age greater than or equal to 18.
You may not qualify if:
- Patients unable to comprehend the investigational nature of the procedure.
- Patients unable to tolerate a temporary reduction of blood volume the equivalent of one unit of blood.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 1999
First Posted
November 4, 1999
Study Start
April 30, 1986
Primary Completion
January 19, 2009
Study Completion
August 17, 2020
Last Updated
August 21, 2020
Record last verified: 2020-08